不应以抗菌药物耐药为由限制多西环素暴露后预防用于细菌性性传播感染
本文为评论性文章,讨论在男男性行为者和跨性别女性中实施多西环素暴露后预防(doxy-PEP)用于细菌性性传播感染预防时,抗菌药物耐药担忧不应成为限制推广的理由。文中指出doxy-PEP对梅毒和衣原体有确切效果,对淋病的效果随四环素耐药背景水平而异,并建议在实施中纳入对淋球菌等局部耐药的评估与监测。
要点
- doxy-PEP对梅毒和衣原体有确切预防效果,不应因耐药担忧阻碍推广。
- 对淋病的效果随四环素耐药背景水平而异,需监测局部淋球菌耐药。
- 应减少动物饲料中四环素使用及其他医疗场景的过度使用。
核心结论
- 在男男性行为者/跨性别女性中,doxy-PEP的实施不应因抗菌药物耐药担忧而受阻。
- 应通过减少动物饲料四环素使用及其他医疗过度使用来应对耐药,并在实施中评估监测局部耐药。
研究设计与样本
- 本文为评论性文章,未报告研究设计、样本量或系统检索范围。
主要发现
- doxy-PEP在男男性行为者和跨性别女性中可减少梅毒和衣原体。
- doxy-PEP对淋病的效果随四环素耐药背景水平而异。
关键数值与推荐
- 部分性健康组织因抗菌药物耐药担忧建议限制doxy-PEP广泛实施。
- doxy-PEP实施应包含对局部抗菌药物耐药的评估与监测,包括淋病奈瑟菌。
临床怎么用
- 在男男性行为者/跨性别女性中推进doxy-PEP实施,同时建立局部淋球菌等耐药监测。
- 推动减少动物饲料四环素使用及其他医疗场景过度使用,以平衡获益与耐药风险。
局限性
- 本文为评论性文章,未提供原始研究数据、样本量或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bacterial sexually transmitted infections, including syphilis, chlamydia, and gonorrhea, continue to rise in key populations despite prevention efforts. Doxycycline postexposure prophylaxis (doxy-PEP) has demonstrated efficacy in reducing syphilis and chlamydia in men who have sex with men and transgender women, with variable effects on gonorrhea depending on background levels of tetracycline resistance. However, some sexual health organizations recommend limiting widespread implementation because of antimicrobial resistance concerns. Given the demonstrated efficacy of doxy-PEP among men who have sex with men/transgender women, implementation efforts should not be hindered by concerns related to antimicrobial resistance. Instead, efforts to reduce tetracycline use in animal feed are warranted, as are efforts to reduce overuse in other medical conditions. Doxy-PEP implementation should include efforts related to evaluation and monitoring of local antimicrobial resistance including Neisseria gonorrhoeae. This approach upholds the ethical principle of beneficence (providing efficacious care to patients) while addressing public health concerns related to antimicrobial resistance.
引用
- Mishriky F, Chan PA. Antimicrobial Resistance Concerns Should not Limit Doxycycline Postexposure Prophylaxis Implementation for Bacterial Sexually Transmitted Infection Prevention. Clin Infect Dis. 2026. PMID: 41661126. doi:10.1093/cid/ciag075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。